https://www.selleckchem.com/products/KU-55933.html
Health risks were measured via validated self-report instruments. Treatment initiation and utilization were measured via self-report and chart review. SHE did not impact women's number of health risks (all p's .05). However, women randomized to SHE showed significantly greater increases in treatment use compared to women in the control group, as measured by chart review (χ (1, n = 153) = 4.38, p = .036, r = .16), and self-report (χ (1, n = 13 = 5.89, p = .015, r = .21). SHE was found to be an acceptable intervention. SHE was eff
お気に入り
コメント
シェア
